ClinConnect ClinConnect Logo
Search / Trial NCT06223945

Thrombohemorrhagic Complications of COVID-19

Launched by VOLGOGRAD STATE MEDICAL UNIVERSITY · Jan 24, 2024

Trial Information

Current as of June 12, 2025

Active, not recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to improve treatment for patients with COVID-19 who experience serious complications related to blood clots or bleeding. These complications, known as thrombohemorrhagic issues, can make the illness even more dangerous. The research will gather information from multiple hospitals across different cities that treated these patients during the pandemic. By analyzing this data, the goal is to create guidelines that help doctors better prevent and treat these complications in COVID-19 patients.

To be eligible for this study, patients need to have had thrombohemorrhagic complications while being treated in a COVID-19 hospital. However, patients with cancer, those who had similar blood issues before being admitted, pregnant women, and those who were already on blood-thinning medications before hospitalization will not be included. While the study is currently active, it is not recruiting new participants. Overall, the findings from this trial aim to improve outcomes for patients facing these serious complications related to COVID-19.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with thrombohemorrhagic complications who were treated in a covid hospital
  • Exclusion Criteria:
  • Cancer patients
  • Patients who had thrombohemorrhagic disorders before admission to the hospital
  • Pregnant women
  • Patients receiving routine anticoagulant and antiplatelet therapy before admission to the hospital

About Volgograd State Medical University

Volgograd State Medical University is a prestigious educational and research institution dedicated to advancing medical science and healthcare. Located in Volgograd, Russia, the university is renowned for its commitment to clinical excellence, innovative research, and the training of skilled healthcare professionals. As a clinical trial sponsor, Volgograd State Medical University plays a pivotal role in conducting rigorous and ethical clinical research, contributing to the development of new therapies and improving patient outcomes. The university collaborates with various stakeholders in the medical field to ensure the highest standards of scientific integrity and patient safety in all its research initiatives.

Locations

Volgograd, , Russian Federation

Patients applied

0 patients applied

Trial Officials

Viktor Mikhin

Study Chair

Volgograd State Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported